Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateSector Deep DivesUploadPipelinePE CyclesBrainAboutHow We Research

Data updated weekly. Not financial advice.

sectoralpha · stock story
Pharma - Formulators →
Home›Stocks›Lupin Ltd
LUPINLupin LtdPharma - Formulators
₹2,398+21.0% 1y

Lupin Ltd (LUPIN) — share price & stock analysis

From losses in FY20 and FY22 to record profits — and the market still prices it like the bad old days.

TURNAROUND, CHEAP VS HISTORYBeating NIFTY 500 for 31 weeks
STAGE 2 UPTRENDBEATING NIFTY 31W
TURNAROUNDMARGINS EXPANDINGLOW DEBTCHEAP VS HISTORY
DEEP CYCLICALEXPANSION
₹1,09,622 Cr
Market cap
19×
P/E
29.1%
ROE
lowest ever
vs own 10-yr valuation
By Sector Alpha Research · machine-compiled from Screener.in data · Updated 1 July 2026 · Sources: Screener.in company page, NSE quote · Not investment advice
The 30-second answer

Lupin Ltd (LUPIN) trades at ₹2,398 as of 1 July 2026, up 21% over the past year — beating NIFTY 500 for 31 weeks. The machine reads this as turnaround, cheap vs history: from losses in FY20 and FY22 to record profits — and the market still prices it like the bad old days. It trades at a P/E of 19.0× (the lowest of its own range); the price is in Stage 2 — advancing, 30 weeks in; the business cycle reads DEEP CYCLICAL / EXPANSION. Fundamentals-momentum score: 93/100 (mostly improving).

Data as of 1 July 2026 · every number traces to its Screener source column · not investment advice.

Key numbers
Market cap
₹1,09,622 Cr
P/E
19×
ROE
29.1%
vs own 10-yr valuation
lowest ever
Book value / share
₹491
EPS (TTM)
₹126
10-yr median P/E
28.8×
Revenue (FY26)
₹27,958 Cr
Profit after tax (FY26)
₹5,355 Cr
Weinstein stage
Stage 2 (30 weeks)
Data as of
1 July 2026
MOMENTUM OF THE FUNDAMENTALS
93/100
MOSTLY IMPROVING
Levels: ROCE 30% — a high-quality engine · effectively no debt · margins at an all-time high
SalesUp 32% YoY — 11 straight growth quarters
MarginsOPM 23.3% → 33.3% in a year
ProfitUp 88% YoY
Cash generationOperating cash ₹3,000 Cr → ₹7,334 Cr
Balance sheetDebt is ₹29 per ₹100 of shareholders’ money
Committed ownersPromoters + funds hold 93.9% (a year ago: 93.8%)
DEEP CYCLICAL
Trough
Recovery
Expansion
Peak

Profits swing violently in this business — real losses in FY20 and FY22. That is what “deep cyclical” means: the same company looks brilliant at the top of its cycle and broken at the bottom.net_profit

Where the clock stands now: earnings sit at 100% of their historical range, margins are the best ever printed, and the market pays the cheap end of its range (0th percentile). That reads as EXPANSION — the comfortable middle — but the records are already on the table; from here the bet is that they keep coming.net_profit

One tension to hold: the margins are the best this company has ever printed while the market still prices the stock at the cheap end of its own history. Either the market is late — or it remembers how cycles in this industry end. That disagreement is the actual bet.

5 of the 6 things we track are currently moving the right way — nearly everything is pulling in the same direction.

Where the levels actually stand: ROCE 30% — a high-quality engine; effectively no debt; margins at an all-time high. Momentum says which way things are moving; these say where they are.

Read this number for what it is: it measures the DIRECTION of change, not the quality of the business. A mediocre business getting better scores high here; a great one having a soft quarter scores low. Profit, sales and margins count double, and a quarter of the score comes from our earnings-recovery lens (is the profit cycle turning up off its trough?).

THE ONE CHART THAT MATTERS

Earnings moved first — the price is still catching up

Since Mar 2016, earnings per share grew 151% while the stock is up 64%. The business has outrun its own share price.pricettm_eps

When profits grow faster than the price, the stock quietly gets cheaper while doing better — the market hasn’t fully caught up.

Today’s P/E of 19× is about the cheapest this stock has ever traded against its own 10-year history.pe_ratio

One caveat: this history includes FY20 and FY22, when earnings collapsed and the P/E was sky-high. “Cheapest ever” partly reflects earnings finally normalising, not just a cheap price.net_profit

And the sharper caveat: today’s margins are the best this company has ever printed. The cheap multiple is only real if they hold — earnings at record profitability flatter every valuation ratio.operating_profit

Price, earnings per share, and the P/E the market pays₹ · ×valuation_history
5001,0001,5002,0002,5000100₹ price₹ EPS₹2,398EPS ₹126P/E ×100200med 29×19×Mar 16Sep 19Mar 23Jul 26
Data: Price, EPS and valuation (sampled — full series in the embedded dataset)
PeriodPrice (₹)EPS (TTM) (₹)P/E (×)
Mar 161,524–33.3
Jun 161,45050.228.9
Aug 161,58257.127.7
Oct 161,50062.524.0
Dec 161,48764.923.8
Mar 171,44764.922.3
May 171,31864.920.3
Jul 171,06445.123.6
Oct 171,03945.023.1
Dec 1786040.421.3
Feb 1880831.325.8
May 1879631.325.4
Jul 188666.2139.4
Sep 1889031.528.3
Nov 18887–32.6
Feb 198314.3191.4
Apr 19836–192.6
Jun 19755––
Sep 19773––
Nov 19742––
Jan 20740––
Apr 20656––
Jun 20912––
Aug 20981––
Oct 20909––
Jan 211,039––
Mar 211,00523.842.2
May 211,20926.845.1
Aug 211,151–44.4
Oct 21947–26.0
Dec 21898––
Mar 22704––
May 22696––
Jul 22640––
Sep 22680––
Dec 22752––
Feb 23670––
Apr 23710––
Jul 239019.595.3
Sep 231,15121.453.9
Nov 231,24329.342.5
Feb 241,503–51.4
Apr 241,62239.441.2
Jun 241,56142.137.1
Aug 242,24049.745.1
Nov 242,10557.636.5
Jan 252,11357.636.7
Mar 252,02863.032.2
Jun 252,00071.927.8
Aug 251,96281.124.2
Oct 251,93181.123.8
Jan 262,10594.822.2
Mar 262,344109.021.5
Apr 262,305108.721.2
Jun 262,272126.218.0
Jul 262,398126.219.0

Price is the weekly close (₹). EPS is trailing-twelve-month profit per share, anchored on Screener's own snapshots; between snapshots it is filled from price ÷ P/E (an exact identity), and any fill straying more than 18% from the neighbouring snapshots is dropped rather than shown. The lower panel is the P/E — what the market pays per rupee of profit; the dotted line is its long-run median (28.8×).

WHERE THE PRICE IS IN ITS CYCLE

An uptrend that has held for 30 weeks

STAGE 2 · ADVANCING · 30 WEEKS

Every stock cycles through the same four seasons — a flat base (stage 1), an advance (2), a top (3), a decline (4). Right now this one is in Stage 2: advancing, 30 weeks in, confirmed.stage

The price sits above its rising 200-day average (₹2,200 today) — trends like this persist more often than they reverse, which is why the system rides them instead of guessing the top.dma_200

Beating NIFTY 500 for 31 weeks — relative strength is the market’s live opinion, and right now it is on this stock’s side.rs_mansfield

What would end it: two Friday closes in a row below the 200-day line. That is the house exit rule — mechanical, no debates.dma_200

Weekly price with its 200-day and 50-day averages — stages shaded₹weinstein_stages
S4S25001,0001,5002,0002,500Price200-DMAStage 2 began · Dec 25Feb 16Aug 19Mar 23Jul 26
Data: Weekly price, moving averages and stage (sampled — full series in the embedded dataset)
PeriodPrice (₹)200-DMA (₹)50-DMA (₹)Stage
Feb 161,7271,7721,7704
May 161,5051,7011,6114
Aug 161,5821,6471,6164
Nov 161,4211,5901,5154
Jan 171,4921,5431,4904
Apr 171,4081,5041,4504
Jul 171,1391,3591,1724
Oct 171,0391,2081,0234
Dec 178851,0728884
Mar 187359688174
Jun 189138897954
Sep 189598838714
Nov 188878788664
Feb 197788598304
May 197538368154
Aug 197597987604
Nov 197667717354
Jan 207407667561
Apr 208227286854
Jul 208617968722
Oct 201,0288689682
Dec 209769029432
Mar 211,0059641,0312
Jun 211,2301,0381,1572
Sep 219701,0581,0562
Nov 219151,0069424
Feb 227689528744
May 226968667584
Aug 226687606464
Oct 226967256784
Jan 237557337402
Apr 236717106764
Jul 239017508162
Sep 231,1718911,0712
Dec 231,2651,0291,2102
Mar 241,6371,2521,5462
Jun 241,6301,4071,6112
Aug 242,2401,6131,9362
Nov 242,0711,8552,1222
Feb 251,9701,9832,1282
May 252,0371,9962,0383
Aug 251,8671,9801,9564
Oct 251,9311,9691,9561
Jan 262,1782,0182,0942
Apr 262,3342,1222,2632
Jun 262,2932,1812,2812
Jul 262,3982,2002,3082
THE LONG ARC

A business that went through the fire — losses in FY20 and FY22, records now

Over 12 years, sales went from ₹11,286 Cr to ₹27,958 Cr (about 8% a year), and profit from ₹1,870 Cr to ₹5,355 Cr.revenuenet_profit

The books show real losses in FY20 and FY22 (worst: ₹−1,528 Cr). Everything about today’s cheap-looking numbers must be read against that history — the recovery is what you are buying.net_profit

Revenue by year₹ Crannual_results
010,00020,00030,000FY14FY19FY24FY26
Data: Revenue by year
PeriodRevenue (₹ Cr)
FY1411,286
FY1512,770
FY1614,256
FY1717,367
FY1815,797
FY1914,665
FY2015,375
FY2115,163
FY2216,405
FY2316,642
FY2420,011
FY2522,708
FY2627,958
Profit by year₹ Crannual_results
02,5005,000FY14FY19FY24FY26
Data: Profit by year
PeriodProfit after tax (₹ Cr)
FY141,870
FY152,444
FY162,270
FY172,565
FY18258
FY19615
FY20-270
FY211,228
FY22-1,528
FY23448
FY241,936
FY253,306
FY265,355
OPM % by year%annual_results
0.010.020.030.0FY14FY19FY24FY26
Data: OPM % by year
PeriodOPM % (%)
FY1426.7
FY1528.4
FY1625.9
FY1725.9
FY1819.9
FY1917.5
FY2015.3
FY2116.9
FY221.3
FY2310.3
FY2419.0
FY2523.2
FY2631.5
CHAPTER 1 · THE ENGINE

Sales jumped 32% last quarter — growth every single quarter for over 2 years

Revenue — the money that comes in from customers, before any costs.

Mar 26 sales were ₹7,475 Cr, up 32% on the same quarter last year.revenue

That makes 11 quarters of growth in a row — this is a trend, not a blip.revenue

Quarterly sales₹ Crquarterly_results
02,5005,0007,500YoY %+24+24+32Jun 23Jun 24Jun 25Mar 26
Data: Quarterly sales
PeriodRevenue (₹ Cr)YoY growth (%)
Jun 234,814–
Sep 235,039–
Dec 235,197–
Mar 244,961–
Jun 245,60016.3
Sep 245,67312.6
Dec 245,76811.0
Mar 255,66714.2
Jun 256,26811.9
Sep 257,04824.2
Dec 257,16824.3
Mar 267,47531.9
WATCH →If quarterly growth slips below 16%, the story weakens.
CHAPTER 2 · THE TAKE

Margins are widening — 23% → 33% in a year

Margins — the share of every ₹100 of sales kept as profit. Gross (after raw materials), operating (after running costs), net (after everything).

Of every ₹100 of sales, the company keeps ₹33.3 as operating profit (a year ago it kept ₹23.3).opm_pct

Zoom out and this is the page's quiet hero: annual operating margin bottomed at 1.3% in FY22 and has been rebuilt to 31.5% — that recovery, not sales alone, is what powers the profit growth elsewhere on this page.operating_profit

The gross margin moved the same way (70% → 75%), so this is about input costs and pricing power — the raw-material equation improved.gpm_pctopm_pct

Three margins, quarterly%margin_trends
20.040.060.080.0GrossOperatingNetJun 23Jun 24Jun 25Mar 26
Data: Three margins, quarterly
PeriodGross (%)Operating (%)Net (%)
Jun 2365.917.89.4
Sep 2366.218.29.8
Dec 2366.820.011.9
Mar 2468.320.17.4
Jun 2468.922.214.4
Sep 2470.223.615.2
Dec 2470.223.514.9
Mar 2570.323.313.8
Jun 2571.727.619.5
Sep 2574.133.221.1
Dec 2573.831.621.1
Mar 2675.233.320.9
WATCH →Two consecutive quarters of margin decline would break this trend.
CHAPTER 3 · THE BOTTOM LINE

Profit exploded 88% — mostly from keeping more of each sale

PAT (profit after tax) — what is left for shareholders after every cost, interest and tax.

Mar 26 profit after tax was ₹1,469 Cr, up 88% year on year.net_profit

Quarterly profit after tax₹ Crquarterly_results
05001,0001,500YoY %+78+74+39+113+52+73+38+88Jun 23Jun 24Jun 25Mar 26
Data: Quarterly profit after tax
PeriodPAT (₹ Cr)YoY growth (%)
Jun 23453–
Sep 23495–
Dec 23619–
Mar 24368–
Jun 2480677.9
Sep 2485973.5
Dec 2485938.8
Mar 25782112.5
Jun 251,22151.5
Sep 251,48572.9
Dec 251,18137.5
Mar 261,46987.9
Where the profit change came from (Mar 25 → Mar 26)₹ Cr
782+422+744−48−54−31−3451,469PAT Mar 25More salesFattermarginsOther incomeDepreciationInterestTaxPAT Mar 26

The single biggest driver was keeping more of each sale.

Data: Where the profit change came from (Mar 25 → Mar 26)
ComponentEffect (₹ Cr)
PAT Mar 25782
More sales+422
Fatter margins+744
Other income−48
Depreciation−54
Interest−31
Tax−345
PAT Mar 261,469
CHAPTER 4 · THE ACID TEST

The profits are real — they turn into cash

Operating cash flow (CFO) — the cash that actually arrived, vs PAT, the profit accounting reports. Annual figures.

Over the last 4 profitable years, the business reported ₹11,045 Cr of profit and collected ₹15,879 Cr of operating cash — about 144% conversion (1 loss year excluded — a negative denominator would flatter the ratio).operating_cash_flownet_profit

One asterisk on that strength: suppliers are being paid 50 days later than a year ago (158 → 208 days). Cash flattered by stretching payables is real cash — but it is borrowed timing, not extra earning power.payable_days

Cash collected vs profit reported (annual)₹ Crcash_flow
02,5005,0007,500Operating cash flowProfit after taxFY14FY19FY24FY26
Data: Cash collected vs profit reported (annual)
PeriodOperating cash flow (₹ Cr)Profit after tax (₹ Cr)
FY142,0041,870
FY152,7332,444
FY16-3822,270
FY174,1142,565
FY181,751258
FY191,666615
FY201,469-270
FY211,8221,228
FY22367-1,528
FY231,897448
FY243,6481,936
FY253,0003,306
FY267,3345,355
CHAPTER 5 · THE PIPELINE

The cash cycle looks tighter — but it is supplier credit doing the work

Working capital — days of sales locked up in inventory and unpaid bills. Screener reports this yearly, so this chart is annual.

One rupee now takes about 181 days to go out the door as materials and come back as collected cash — down from 223 days the year before.cash_conversion_cycle

Look inside the improvement, though: suppliers are being paid 50 days later (158 → 208 days), while inventory actually got heavier (292 → 303 days). Supplier credit is funding the cycle — useful, but not the same thing as customers paying faster.payable_daysinventory_days

Days of cash locked up (annual)daysratios
100200300Customers owe (debtor days)Stock on shelf (inventory days)We owe suppliers (payable days)FY14FY19FY24FY26
Data: Days of cash locked up (annual)
PeriodCustomers owe (debtor days) (days)Stock on shelf (inventory days) (days)We owe suppliers (payable days) (days)
FY1480.0204152
FY1576.0220172
FY16116276168
FY1791.0266189
FY18120253178
FY19128283184
FY20129232162
FY21108279137
FY2295.0261129
FY2398.0242136
FY2486.0272163
FY2588.0292158
FY2686.0303208
CHAPTER 6 · THE BUILD

The asset base keeps compounding — this company builds

Capex — money spent on plants, machines and buildings. Gross block is what exists; CWIP (capital work-in-progress) is what is being built. Annual.

The productive asset base has gone from ₹3,356 Cr (FY14) to ₹11,315 Cr, with another ₹695 Cr of capacity under construction right now.fixed_assetscwip

The build is self-funded: the last 3 years' investing outflow (₹9,749 Cr) fits inside the operating cash the business generated (₹13,982 Cr).investing_cash_flowoperating_cash_flow

Assets in place vs under construction (annual)₹ Crbalance_sheet
05,00010,000Fixed assetsUnder construction (CWIP)FY14FY19FY24FY26
Data: Assets in place vs under construction (annual)
PeriodFixed assets (₹ Cr)Under construction (CWIP) (₹ Cr)
FY143,356304
FY154,368576
FY168,7172,702
FY1711,0332,133
FY1810,3622,598
FY1911,0871,640
FY207,938940
FY217,8811,066
FY227,3821,146
FY238,3551,238
FY248,878773
FY259,719517
FY2611,315695
CHAPTER 7 · SURVIVAL

Debt is small — but no longer zero, and growing

Debt-to-equity — borrowings against shareholders’ money. Computed from the balance sheet. Annual.

For every ₹100 shareholders have put in (and left in), the company has borrowed ₹29 — total borrowings have grown from ₹654 Cr to ₹6,616 Cr over the window.borrowings

The equity base grew even faster, so the ratio stays comfortable — but a 10× rise in absolute borrowings deserves a name (acquisitions, capex), not a shrug. Watch whether it keeps compounding.borrowings

Total borrowings (annual)₹ Crbalance_sheet
05,000FY14FY19FY24FY26
Data: Total borrowings (annual)
PeriodBorrowings (₹ Cr)
FY14654
FY15537
FY167,178
FY177,966
FY187,143
FY198,496
FY206,305
FY214,783
FY224,158
FY234,542
FY242,922
FY255,448
FY266,616
Debt vs shareholders’ money (annual)xbalance_sheet
00.20.40.6FY14FY19FY24FY26
Data: Debt vs shareholders’ money (annual)
PeriodDebt ÷ equity (x)
FY140.1
FY150.1
FY160.6
FY170.6
FY180.5
FY190.6
FY200.5
FY210.4
FY220.3
FY230.4
FY240.2
FY250.3
FY260.3
CHAPTER 8 · THE ENGINE ROOM

Every ₹100 kept in the business now earns ₹30 — and the number is rising

ROCE — profit earned per ₹100 of capital used. ROE — the same, per ₹100 of shareholders’ money alone. Annual.

Return on capital employed is 30.0% (a year ago: 21.0%). This is the single best test of business quality: what the company earns on the money it keeps.roce_pct

Rising returns on capital while growing is the rarest combination in investing — it means the new projects earn more than the old ones.roce_pct

Returns on capital (annual)%ratios
0.020.040.0ROCEFY14FY19FY24FY26
Data: Returns on capital (annual)
PeriodROCE (%)
FY1441.0
FY1540.0
FY1624.0
FY1719.0
FY1810.0
FY1910.0
FY209.0
FY219.0
FY22-7.0
FY236.0
FY2416.0
FY2521.0
FY2630.0
CHAPTER 9 · WHO OWNS IT

The owners aren’t moving

Shareholding — who owns the company: founders (promoters), foreign funds (FII), domestic funds (DII).

Promoters hold 46.9%, essentially unchanged. Foreign funds own 21.7%, domestic funds 25.3%.promoters_pctfiis_pctdiis_pct

Institutions buying while the story develops is the market’s quiet vote of confidence — they meet management, you don’t.

Meanwhile domestic funds have been the sellers — from 29.1% to 25.3% over the window. Someone on the other side of the table disagrees; both sides count.diis_pct

Who holds the shares, quarterly%shareholding
Promoters47.1% → 46.9% · flat
46.947.0Jun 23Jun 24Jun 25Mar 26
Foreign funds13.9% → 21.7% · up 7.8 pts
15.017.520.022.5Jun 23Jun 24Jun 25Mar 26
Domestic funds29.1% → 25.3% · down 3.8 pts
26.028.030.0Jun 23Jun 24Jun 25Mar 26
Data: Who holds the shares, quarterly
PeriodPromoters (%)Foreign funds (%)Domestic funds (%)
Jun 2347.113.929.1
Sep 2347.115.029.1
Dec 2347.016.129.7
Mar 2447.018.327.8
Jun 2447.019.326.8
Sep 2447.021.525.1
Dec 2446.922.024.7
Mar 2546.921.525.4
Jun 2546.921.325.6
Sep 2546.920.526.6
Dec 2546.921.525.6
Mar 2646.921.725.3
WHAT IS NOT HAPPENING
  • Promoters are not selling. Their stake has moved 0.1 points or less in 8 quarters — it sits at 46.9%.promoters_pct
THE VERDICT

The numbers earn a deeper study — and watch the one thing that matters

The numbers lean positive, and the price hasn’t fully caught up with the improvement.

Best thing in the data: free cash flow rising (₹−1,172 Cr → ₹3,469 Cr).operating_cash_flow

The machine committee — 7 independent readsSTUDY DEEPER · 78%
Earnings patternPOSITIVE90% · w21
Valuation cyclePOSITIVE98% · w19
CatalystsNEUTRAL40% · w14
Quality & safetyNEUTRAL42% · w14
TechnicalsPOSITIVE36% · w12
ValuationPOSITIVE90% · w10
Growth at a pricePOSITIVE78% · w10
Business quality8.0/10
Management6.5/10
7-model research readSTUDY DEEPER · 78% confidence
WHAT WOULD CHANGE THIS VIEWTwo quarters of margins reversing would kill this story.

Machine-written research from Screener data — every number traces to its source column. Sector Alpha is not a SEBI-registered investment adviser; nothing here is a recommendation to buy or sell. Not investment advice.

More Pharma - Formulators stocks
Sun Pharmaceutical Industries LtdTorrent Pharmaceuticals LtdCipla LtdDr Reddys Laboratories LtdZydus Lifesciences LtdMankind Pharma LtdAll Pharma - Formulators stocks →
Frequently asked questions

Straight answers from the data

What does Lupin Ltd do?

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions. It is listed in the Pharma - Formulators sector with a market capitalisation of ₹1,09,622 Cr.

What is Lupin Ltd's share price?

As of 1 July 2026, Lupin Ltd trades at ₹2,398, up 21% over the past year, with a market capitalisation of ₹1,09,622 Cr. Beating NIFTY 500 for 31 weeks. Prices are weekly closes from Screener data; this page refreshes with each weekly update.

What is Lupin Ltd's share price target?

Sector Alpha does not publish broker-style price targets. Our discounted-cash-flow model estimates Lupin Ltd's intrinsic value at ₹6,414 per share under base assumptions (bear ₹2,012, bull ₹6,414), against the current price of ₹2,398 — a 174% margin of safety. The current price already implies roughly 11% annual earnings growth. These are model estimates, not forecasts — treat them as one input alongside the valuation history below, not as a target.

Is Lupin Ltd stock overvalued or undervalued?

Lupin Ltd trades at a P/E of 19.0× — the lowest of its own 10.3-year trading range (median 28.8×). Earnings moved first — the price is still catching up. Since Mar 2016, earnings per share grew 151% while the stock is up 64%. The business has outrun its own share price. One caveat: margins are currently above their own all-time band, so the earnings behind that multiple may themselves be at a cyclical high — the stock is cheaper than its history partly because the E is fatter than usual.

What did Lupin Ltd report in its latest quarterly results?

In its most recent reported quarter (Q4 FY26, quarter ended March 2026): Mar 26 sales were ₹7,475 Cr, up 32% on the same quarter last year. Mar 26 profit after tax was ₹1,469 Cr, up 88% year on year. Figures are from Screener-scraped quarterly filings; the page updates when the next quarter is filed.

Is Lupin Ltd growing?

Sales jumped 32% last quarter — growth every single quarter for over 2 years. Mar 26 sales were ₹7,475 Cr, up 32% on the same quarter last year.

Are Lupin Ltd's profits growing?

Profit exploded 88% — mostly from keeping more of each sale. Mar 26 profit after tax was ₹1,469 Cr, up 88% year on year.

What are Lupin Ltd's operating margins?

Margins are widening — 23% → 33% in a year. In the most recent quarter, of every ₹100 of sales, the company keeps ₹33.3 as operating profit (a year ago it kept ₹23.3).

What is Lupin Ltd's long-term growth record?

Revenue grew from ₹11,286 Cr in FY14 to ₹27,958 Cr in FY26 — a 7.9% compound annual growth rate over 12 years. Profit after tax compounded at 9.2% over the same period (₹1,870 Cr → ₹5,355 Cr).

Is Lupin Ltd stock in an uptrend?

An uptrend that has held for 30 weeks. Lupin Ltd is in Stage 2 — advancing, 30 weeks in (confirmed). Stages follow Stan Weinstein's four-phase read of weekly price against the 200-day average: basing (1), advancing (2), topping (3), declining (4).

Why is Lupin Ltd stock rising?

The price is up 21% over the past year, in a confirmed Stage 2 uptrend (30 weeks), and has beaten NIFTY 500 for 31 weeks. Since 2016, the price is up 64% while earnings per share moved 151%.

Is Lupin Ltd beating the NIFTY 500?

Yes — beating NIFTY 500 for 31 weeks, as of 1 July 2026. Relative strength is measured weekly against the NIFTY 500 (Mansfield RS): a positive reading means the stock has outperformed the index over the trailing window, week after week.

Where is Lupin Ltd in its business cycle?

The data reads Lupin Ltd as a deep cyclical business currently in its expansion phase — earnings at an all-time high for this company, valuation at its all-time lows. Profits swing violently in this business — real losses in FY20 and FY22. That is what “deep cyclical” means: the same company looks brilliant at the top of its cycle and broken at the bottom.

Who owns Lupin Ltd — what is the promoter holding?

Promoters hold 46.9%, essentially unchanged. Foreign funds own 21.7%, domestic funds 25.3%. Institutions buying while the story develops is the market’s quiet vote of confidence — they meet management, you don’t. Shareholding is from Screener's quarterly filings data.

Does Lupin Ltd have too much debt?

Debt is small — but no longer zero, and growing. For every ₹100 shareholders have put in (and left in), the company has borrowed ₹29 — total borrowings have grown from ₹654 Cr to ₹6,616 Cr over the window.

What is the bull case for Lupin Ltd?

From losses in FY20 and FY22 to record profits — and the market still prices it like the bad old days. Best thing in the data: free cash flow rising (₹−1,172 Cr → ₹3,469 Cr). Sales jumped 32% last quarter — growth every single quarter for over 2 years.

What is the bear case for Lupin Ltd — what could break the story?

Two quarters of margins reversing would kill this story. The nearest-term thing to watch: if quarterly growth slips below 16%, the story weakens. This falsification condition is stated up front so the thesis can be checked against incoming quarters, not defended after the fact.

Is Lupin Ltd a stock worth studying right now?

Sector Alpha does not publish buy or sell recommendations — this is a research read, not advice. What the data says: the numbers earn a deeper study — and watch the one thing that matters. The numbers lean positive, and the price hasn’t fully caught up with the improvement. Across the 7-model scorecard the composite research signal is study deeper at 78% confidence. This is machine-written research compiled from Screener data — every number traces to its source — and it is not investment advice. Do your own diligence.

Generated from Screener data · 12 sources · why_traces/1.0 + story/1.2
details
generated 2026-07-03 11:21 · 6 material moves detected
sources: screener_company_info, screener_quarterly_results, screener_annual_results, screener_valuation_history, screener_shareholding, screener_cash_flow, screener_ratios, screener_balance_sheet, screener_margin_trends, weinstein_stages, agent_scores, stock_timelines